Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BKD
BKD logo

BKD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Brookdale Senior Living Inc (BKD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
13.540
1 Day change
-1.46%
52 Week Range
17.090
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Brookdale Senior Living Inc (BKD) is not a strong buy at this time for a beginner investor with a long-term strategy. While there are some positive catalysts such as bullish analyst ratings and price targets, the weak financial performance and hedge fund selling trend outweigh the positives. The stock's technical indicators suggest a neutral to slightly bullish trend, but the lack of a strong proprietary trading signal and recent financial underperformance make it prudent to hold rather than buy.

Technical Analysis

The technical indicators for BKD show a slightly bullish trend. The MACD is positive and expanding, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). RSI is neutral at 62.655, and the stock is trading above its pivot point of 13.845. However, the post-market price drop of -1.56% indicates some short-term weakness.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
3

Positive Catalysts

  • Analysts have consistently raised price targets, with the most recent targets ranging from $17 to $19.50, indicating strong confidence in the company's future performance.

  • The company's private-pay model reduces exposure to government reimbursement risks, which is seen as a structural advantage.

  • Gross margin improved by 16.49% YoY in Q4 2025, showing some operational efficiency gains.

Neutral/Negative Catalysts

  • Hedge funds are aggressively selling, with a 885.30% increase in selling over the last quarter.

  • The company's financial performance in Q4 2025 was weak, with revenue, net income, and EPS all showing significant declines YoY.

  • No recent news or event-driven catalysts to support a strong upward move.

Financial Performance

In Q4 2025, the company reported a revenue decline of -3.44% YoY to $754.09M. Net income dropped significantly by -52.38% YoY to -$39.96M, and EPS fell by -54.05% YoY to -$0.17. However, gross margin improved by 16.49% YoY to 14.69%, indicating some operational improvements despite overall weak financial results.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are bullish on BKD, with multiple firms raising price targets recently. The most recent price targets range from $17 to $19.50, and ratings are predominantly Buy or Overweight. Analysts highlight the company's mid-teens EBITDA growth outlook, improved occupancy rates, and disciplined pricing as key drivers for future growth.

Wall Street analysts forecast BKD stock price to fall
3 Analyst Rating
Wall Street analysts forecast BKD stock price to fall
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 13.740
sliders
Low
13
Averages
13.33
High
14
Current: 13.740
sliders
Low
13
Averages
13.33
High
14
Stephens
Overweight
initiated
$18
AI Analysis
2026-04-08
Reason
Stephens
Price Target
$18
AI Analysis
2026-04-08
initiated
Overweight
Reason
Stephens initiated coverage of Brookdale Senior Living with an Overweight rating and $18 price target. Brookdale Senior represents an adjacent exposure aligned with the structural shift towards lower-cost care settings, says the analyst, who adds that the company's largely private-pay model mitigates exposure to government reimbursement risk.
BofA
Joanna Gajuk
Buy
maintain
$18
2026-02-19
Reason
BofA
Joanna Gajuk
Price Target
$18
2026-02-19
maintain
Buy
Reason
BofA analyst Joanna Gajuk raised the firm's price target on Brookdale Senior Living to $19.50 from $18 and keeps a Buy rating on the shares. After a Q4 print as pre-announced and guidance being reaffirmed, the firm maintains its adjusted EBITDA estimates and raised its multiple given the strong underlying trends.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BKD
Unlock Now

People Also Watch